Another study reported that endogenous NO plays a vital role in defining the stemness properties of colon cancer stem cells, and either a specific iNOS inhibitor or a genetic knock-down of iNOS significantly reduced the tumourigenic capacities of colon cancer stem cells (69). Here, NOS2 is linked to malignant colon neoplasm.